Concert Pharma Stock Price (NASDAQ:CNCE)

Add to My Stocks
$16.1 $2.07 (14.75%) CNCE stock closing price Jul 24, 2017 (Closing)
Prev Close* : $14.03
Market Cap:
Day Low: $14.33
52 Week Low: $7.11
Open: $14.36
Volume: 882866
Day High: $16.5
52 Week High: $19.11

Latest Stock Market News

Latest Articles

Concert Pharma News - From Partners

CNCE Stockcharts

View CNCE PE ratio, PS ratio stocks charts and compare with peers.
CNCE Chart
Note: Compare Concert Pharma stock price history with the index and industry peers.

Concert Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Concert Pharma Financial Ratios

Receivables Turnover

CNCE Industry Peers

Company Price Change (%)
Tetraphase Pharmaceuticals (TTPH)7.30.79 (9.77%)
Rigel Pharma (RIGL)2.610 (0%)
Celgene (CELG)137.840.1 (0.07%)
Jazz Pharma (JAZZ)160.980.15 (0.09%)
Vertex Pharma (VRTX)166.112.94 (1.8%)
Auspex Pharma (ASPX)100.960 (0%)
Proteostasis (PTI)3.510.14 (3.84%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
AcelRx Pharma (ACRX)3.650.5 (15.87%)
Genocea Biosciences (GNCA)5.830.78 (15.45%)
Concert Pharma (CNCE)16.12.07 (14.75%)
ImmunoGen (IMGN)6.340.68 (12.01%)
GlycoMimetics (GLYC)12.10.6 (5.22%)
Arrowhead Pharma (ARWR)1.580.07 (4.64%)
Catalyst Pharma (CPRX)3.080.13 (4.41%)
Top gainers from Medical-Drugs industry
* As of Jul 24, 2017
CompanyPriceChange (%)
Tetraphase Pharmaceuticals (TTPH)7.30.79 (9.77%)
Endo International (ENDP)11.670.71 (5.74%)
BioCryst Pharma (BCRX)5.20.21 (3.88%)
Corcept Therapeutics (CORT)12.530.44 (3.39%)
Lannett Co (LCI)210.5 (2.33%)
Durect (DRRX)1.840.03 (1.6%)
Grifols (GRFS)20.370.33 (1.59%)
Top losers from Medical-Drugs industry
* As of Jul 24, 2017

Concert Pharmaceuticals Inc Stock News - Partner Headlines

Concert Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues0.17M66.72M8.57M25.4M12.84M
Net Income-50.72M24.17M-31.69M-6.05M-20.44M
Total Operating Expense51.33M41.93M39.17M29.81M31.45M
view Concert Pharmaceuticals Inc income statement
balance sheet20162015201420132012
Total Assets100.39M146.93M84.45M39.77M33.12M
Total Liabilities14.8M16.29M29.62M39.63M27.96M
Shareholders Equity85.59M130.63M54.82M0.14M5.16M
view Concert Pharmaceuticals Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-0.77M-5.39M-1.52M16.79M-8.58M
Net Cash From (Used By) Operating Activities-45.34M23.06M-29.76M13.01M-26.42M
Increase (Decrease) In Prop Plant And Equipment-0.77M-0.86M-0.8M-0.36M-0.46M
view Concert Pharmaceuticals Inc cashflow statement

Concert Pharma Stock Message Board

Concert Pharma stock lost -1.61 %, and the last close price as of 21 Jul, 2017 is 14.03 for CNCE stock. Concert Pharma market capitalization is 321.75M and it represents the total market value of CNCE stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Concert Pharma stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Concert Pharma is worth a lot, it will most likely be reflected in an inflated Concert Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 101739 shares were traded with a closing stock price of 14.03 as of 21 Jul, 2017, as can be seen from Concert Pharma stock quote. One can view Concert Pharma stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Concert Pharma does not pay dividends. One can observe stock price trends and check for volatility by checking Concert Pharma stock price history.